Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Atkins

Showing results (111-120 of 208) with videos related to

Pageof 21
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1985
Phase II trial of vincristine infusion in acute leukemiaD V Jackson, A R Chauvenet, R D Callahan, et al.
Journal of Clinical Monitoring|July 1, 1995
Validation of blood pressure measuring devicesE O'Brien, P Padfield, M Bland, et al.
Biochemical and Biophysical Research Communications|April 25, 2000
Emx1-specific expression of foreign genes using "knock-in" approachX L Jin, H Guo, C Mao, et al.
Journal of Human Hypertension|June 1, 1988
The antihypertensive efficacy of verapamil in the elderly evaluated by ambulatory blood pressure measurementJ P Cox, C A O'Boyle, F Mee, et al.
Cancer|February 22, 2002
Higher doses of mitoxantrone among men with hormone-refractory prostate carcinoma: a Cancer and Leukemia Group B studyEllis G Levine, Susan Halabi, John D Roberts, et al.
American Journal of Epidemiology|August 15, 1992
The increase in blood pressure with age and body mass index is overestimated by conventional sphygmomanometryJ Staessen, E O'Brien, N Atkins, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 27, 2006
Phase II trial of irinotecan/gemcitabine as second-line therapy for relapsed and refractory small-cell lung cancer: Cancer and Leukemia Group B Study 39902C M Rocha-Lima, J E Herndon, M E Lee, et al.
Investigational New Drugs|November 26, 2009
Phase II evaluation of eribulin mesylate (E7389, NSC 707389) in patients with metastatic or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group trial S0618Susanne M Arnold, James Moon, Stephen K Williamson, et al.
Journal of Substance Use and Addiction Treatment|October 10, 2024
Factors affecting problem-solving court team decisions about medications for opioid use disorderBarbara Andraka-Christou, Jill Viglione, Fatema Ahmed, et al.
Optics Express|October 6, 2012
Spectroscopic study of transparency current in mid-infrared quantum cascade lasersDmitry G Revin, Randa S Hassan, Andrey B Krysa, et al.
Pageof 21

Showing results (111-120 of 208) with videos related to

Sort By:
Pageof 21
Cancer Chemotherapy and Pharmacology|January 1, 1985
Phase II trial of vincristine infusion in acute leukemiaD V Jackson, A R Chauvenet, R D Callahan, et al.
Journal of Clinical Monitoring|July 1, 1995
Validation of blood pressure measuring devicesE O'Brien, P Padfield, M Bland, et al.
Biochemical and Biophysical Research Communications|April 25, 2000
Emx1-specific expression of foreign genes using "knock-in" approachX L Jin, H Guo, C Mao, et al.
Journal of Human Hypertension|June 1, 1988
The antihypertensive efficacy of verapamil in the elderly evaluated by ambulatory blood pressure measurementJ P Cox, C A O'Boyle, F Mee, et al.
Cancer|February 22, 2002
Higher doses of mitoxantrone among men with hormone-refractory prostate carcinoma: a Cancer and Leukemia Group B studyEllis G Levine, Susan Halabi, John D Roberts, et al.
American Journal of Epidemiology|August 15, 1992
The increase in blood pressure with age and body mass index is overestimated by conventional sphygmomanometryJ Staessen, E O'Brien, N Atkins, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 27, 2006
Phase II trial of irinotecan/gemcitabine as second-line therapy for relapsed and refractory small-cell lung cancer: Cancer and Leukemia Group B Study 39902C M Rocha-Lima, J E Herndon, M E Lee, et al.
Investigational New Drugs|November 26, 2009
Phase II evaluation of eribulin mesylate (E7389, NSC 707389) in patients with metastatic or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group trial S0618Susanne M Arnold, James Moon, Stephen K Williamson, et al.
Journal of Substance Use and Addiction Treatment|October 10, 2024
Factors affecting problem-solving court team decisions about medications for opioid use disorderBarbara Andraka-Christou, Jill Viglione, Fatema Ahmed, et al.
Optics Express|October 6, 2012
Spectroscopic study of transparency current in mid-infrared quantum cascade lasersDmitry G Revin, Randa S Hassan, Andrey B Krysa, et al.
Pageof 21